Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Thalidomide

EU orphan designation number: EU/3/01/066
Active ingredient: Thalidomide
Indication: Treatment of erythema nodosum leprosum (ENL) or type II lepra reactions
Sponsor: Celgene Europe Limited
Riverside House, Riverside Walk, Windsor, Berkshire SL4 1NA, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/11/2001 Centralised Orphan - Designation EMEA/OD/041/01 (2001)3568 of 20/11/2001
25/07/2005 Other procedure
02/12/2008 Centralised Orphan - Transfer of orphan designation EMEA/OD/041/01/T/01 (2008)7794 of 28/11/2008
09/11/2010 Centralised Orphan - Removal of orphan designation from Community Register